Merck Defends Right Not To Publish Clinical Trials
Executive Summary
Merck believes clinical trial disclosure rules must distinguish between hypothesis-generating and hypothesis-testing trials
You may also be interested in...
Clinical Trials Registration Bill From Democrats Includes Monetary Penalties
A House and Senate bill mandating clinical trial registration uses institutional review board approval and civil monetary penalties to enforce compliance
Clinical Trials Registration Bill From Democrats Includes Monetary Penalties
A House and Senate bill mandating clinical trial registration uses institutional review board approval and civil monetary penalties to enforce compliance
European Reimbursement Model Could Spur Drug Innovation – FasterCures
Providing higher reimbursement for first-in-class drugs is one way to boost innovation in the U.S., FasterCures says in comments to HHS